Jump to content

Malaysia buys 150,000 courses of Merck's COVID-19 pill


Recommended Posts

2021-10-07T061055Z_1_LYNXMPEH9607L_RTROPTP_4_DIVI-S-STOCKS.JPG

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid

 

KUALA LUMPUR (Reuters) - Malaysia has struck a deal with U.S. drugmaker Merck & Co to buy 150,000 courses of its experimental antiviral pill, the health ministry said on Thursday, joining other Asian countries in a rush to secure supplies.

 

Molnupiravir, which would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown.

 

The data sparked large demand for the drug in Asia, with South Korea, Singapore and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in talks to buy it.

 

Malaysia's Health Minister Khairy Jamaluddin said the government signed a letter of undertaking for the purchase on Thursday.

 

"This decision was made as we prepare to transition into an endemic phase, where we can co-exist with the virus by adding new innovative treatments as 'weapons' to fight COVID-19, apart from vaccinations and other public health measures," Khairy said in a statement.

 

Malaysia has recorded nearly 2.3 million COVID-19 infections, the third-highest in Southeast Asia, but has gradually lifted movement restrictions in recent weeks as the number of new cases declined amid a ramped-up vaccination programme.

 

About 64% of Malaysia's 32 million population are now fully vaccinated, including 88% of adults.

 

reuters_logo.jpg

-- © Copyright Reuters 2021-09-13
 

(Reporting by Rozanna Latiff; Editing by Muralikumar Anantharaman)

Link to comment
Share on other sites

I would be careful with that stuff.

 

Merck’s Covid Pill Could Pose Serious Risks, Scientists Warn  https://www.barrons.com/articles/merck-covid-pill-risks-51633398722

 

excerpt:  Molnupiravir works by incorporating itself into the genetic material of the virus, and then causing a huge number of mutations as the virus replicates, effectively killing it. In some lab tests, the drug has also shown the ability to integrate into the genetic material of mammalian cells, causing mutations as those cells replicate.

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.




×
×
  • Create New...